← Open Payments lookup

MARK REGINATO: Open Payments

NPI 1194884502 · DANVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,389 in 161 payments from 49 companies in 2025. Trend: 2023 $3,241 · 2024 $3,319 · 2025 $3,389

Food & beverage: $3,389
CompanyPaymentsAmount
ABBVIE INC.24$348
PFIZER INC.10$217
Amgen Inc.9$168
Novo Nordisk Inc6$155
AstraZeneca Pharmaceuticals LP7$151
GlaxoSmithKline, LLC.6$135
Exact Sciences Corporation5$133
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$126
Esperion Therapeutics, Inc.6$117
Axsome Therapeutics, Inc.4$116

Products named: REXULTI, OTEZLA, UBRELVY, CAPLYTA, NEXLETOL, Auvelity, XIFAXAN, Cologuard Collection Kit.

Industry payments across CA — which companies pay providers there.